Literature DB >> 25362661

Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors.

Annelies Boonen1, Caroline Boone2, Adelin Albert2, Herman Mielants2.   

Abstract

OBJECTIVE: To explore the effect of health-related and contextual factors on presenteeism, absenteeism, and overall work productivity loss in patients with active ankylosing spondylitis (AS).
METHODS: Consecutive patients with AS starting their first tumor necrosis factor inhibitor and in paid employment were eligible. Patients completed the Work Productivity and Activity Impairment (WPAI) questionnaire for AS to assess presenteeism, absenteeism, and overall work productivity loss in the previous 7 days. In addition, they answered questions about work characteristics (type, characteristics of workplace, satisfaction of contacts with colleagues, and importance of work in life) and health status [Bath AS Functional Index (BASFI), AS Disease Activity Score-C-reactive protein (ASDAS-CRP)]. Physicians assessed the Bath Ankylosing Spondylitis Metrology Index, presence of articular and extraarticular manifestations, comorbidities, and laboratory indicators of inflammation. Stepwise regression models were computed to determine which work-related and health-related factors contributed to WPAI outcomes.
RESULTS: The study included 80 patients. The WPAI presenteeism, absenteeism, and overall work productivity loss scores were 49.1%, 30.2%, and 53.1%, respectively. Presenteeism was associated with higher BASFI, female sex, and poor quality of contact with colleagues. Absenteeism was associated with increasing age, current smoking status, higher ASDAS-CRP, and low importance of work for life. Overall work productivity loss was associated with female sex, higher BASFI, past adaptation of job because of illness, number of working hours, and manual profession.
CONCLUSION: Both health-related and contextual factors contribute to work limitations in patients with AS and suggest additional opportunities for improvement by addressing the working environment.

Entities:  

Keywords:  ABSENTEEISM; ANKYLOSING SPONDYLITIS; WORK

Mesh:

Year:  2014        PMID: 25362661     DOI: 10.3899/jrheum.131287

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Axial Spondyloarthritis and Cigarette Smoking.

Authors:  Irène Kona Kaut; Fatima Ezzhara Abourazzak; Essouri Jamila; Florine Awassi Sènami; Desiré Diketa; Harzy Taoufik
Journal:  Open Rheumatol J       Date:  2017-05-31

2.  Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China.

Authors:  Liudan Tu; Ya Xie; Zetao Liao; Yutong Jiang; Qing Lv; Shuangyan Cao; Qiujing Wei; Jieruo Gu
Journal:  Front Public Health       Date:  2020-11-24

3.  Work Outcomes Among Patients with Light Chain (AL) Amyloidosis: Findings from Three Patient Cohorts.

Authors:  Avery A Rizio; Kristen L McCausland; Michelle K White; Tiffany P Quock
Journal:  Patient Relat Outcome Meas       Date:  2021-12-15

4.  Employment, Work Productivity, and Biologic Treatments in Self-Reported Axial Spondyloarthritis: a Cross-Sectional Study in a Female Predominant Population from the ArthritisPower Registry.

Authors:  Kelly Gavigan; W Benjamin Nowell; Theresa Hunter; Jeffrey R Curtis; William N Malatestinic; Rebecca J Bolce; Jeffrey R Lisse; Jessica Walsh
Journal:  Rheumatol Ther       Date:  2022-02-21

5.  Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.

Authors:  Sang-Hoon Lee; Yong-Gil Kim; Seung-Geun Lee; Soo Hyun Lee; Young-Joo Kim; Ja-Young Jeon; Joo-Young Jo; Hyun-Jeong Yoo; Juneyoung Lee; Tae-Hwan Kim
Journal:  Int J Rheum Dis       Date:  2022-02-20       Impact factor: 2.558

6.  Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study.

Authors:  A Deodhar; V Strand; P G Conaghan; E Sullivan; S Blackburn; H Tian; K Gandhi; S M Jugl; R Alten
Journal:  BMC Rheumatol       Date:  2020-03-02

7.  EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.

Authors:  Annelies Boonen; Polina Putrik; Mary Lucy Marques; Alessia Alunno; Lydia Abasolo; Dorcas Beaton; Neil Betteridge; Mathilda Bjørk; Maarten Boers; Boryana Boteva; Bruno Fautrel; Francis Guillemin; Elsa F Mateus; Elena Nikiphorou; Márta Péntek; Fernando Pimentel Santos; Johannes L Severens; Suzanne M M Verstappen; Karen Walker-Bone; Johan Karlsson Wallman; Marieke M Ter Wee; René Westhovens; Sofia Ramiro
Journal:  Ann Rheum Dis       Date:  2021-04-08       Impact factor: 19.103

8.  Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study.

Authors:  Anna Kotulska; Eugeniusz J Kucharz; Piotr Wiland; Marzena Olesińska; Anna Felis-Giemza; Magdalena Kopeć-Mędrek; Aleksandra Zoń-Giebel; Wojciech Romanowski; Lucyna Szymczak-Bartz; Małgorzata Tłustochowicz; Jolanta Lewandowicz; Joanna Kowalska-Majka; Jolanta Bucka; Maria Majdan; Zofia Kiełbik; Mariusz Korkosz; Aneta Bielińska; Piotr Leszczyński; Katarzyna Pawlak-Buś; Mariusz J Puszczewicz; Dominik Majewski; Katarzyna Smolik; Teresa Migas-Kukla; Małgorzata Sochocka-Bykowska; Maria Szarecka; Bernadeta Luberda; Małgorzata Falenta-Hitnarowicz; Jadwiga Świkszcz-Gniadek; Wanda Lepiarz-Rusek; Grzegorz Rozwadowski; Barbara Chara; Jerzy Zajdel; Zbigniew Zdrojewski; Maria Maciejowska-Roge; Irena Rosmus-Kuczia
Journal:  Reumatologia       Date:  2018-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.